The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis
Open accessAbstract
Limited clinical benefits derived from anti-VEGF therapy have driven the identification of new targets involved in tumor angiogenesis. Here, we report an integrative meta-analysis to define the transcriptional program underlying angiogenesis in human cancer. This approach identified ELTD1, an orphan G-protein-coupled receptor whose expression is induced by VEGF/bFGF and repressed by DLL4 signaling. Extensive analysis of multiple cancer types demonstrates significant upregulation of ELTD1 in tumor-associated endothelial cells, with a higher expression correlating with favorable prognosis. Importantly, ELTD1 silencing impairs endothelial sprouting and vessel formation in vitro and in vivo, drastically reducing tumor growth and greatly improving survival. Collectively, these results provide insight into the regulation of tumor angiogenesis and highlight ELTD1 as key player in blood vessel formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Towards a knowledge-based Human Protein Atlas
Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1210-1248 · Cited by 2,440
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Angiogenesis: A Team Effort Coordinated by Notch
Phng, L.-K., & Gerhardt, H. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.015 · Cited by 832
Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries
Siekmann, A. F., & Lawson, N. D. (2007) · Nature · doi:10.1038/nature05577 · Cited by 687
Gale, N. W., Dominguez, M. G., Noguera, I., Pan, L., Hughes, V., Valenzuela, D. M., Murphy, A. J., Adams, N. C., Lin, H. C., Holash, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407290101 · Cited by 600
Dosage‐sensitive requirement for mouse Dll4 in artery development
Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Bekman, E., Costa, L., Henrique, D., & Rossant, J. (2004) · Genes & Development · doi:10.1101/gad.1239004 · Cited by 563
Buffa, F. M., Harris, A. L., West, C. M., & Miller, C. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605450 · Cited by 556
Self-citationHaploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants
Krebs, L. T., Shutter, J. R., Tanigaki, K., Honjo, T., Stark, K. L., & Gridley, T. (2004) · Genes & Development · doi:10.1101/gad.1239204 · Cited by 532
Angiogenic network formation in the developing vertebrate trunk
Isogai, S., Lawson, N. D., Torrealday, S., Horiguchi, M., & Weinstein, B. M. (2003) · Development · doi:10.1242/dev.00733 · Cited by 519
Identification and functional analysis of endothelial tip cell–enriched genes
del Toro, R., Prahst, C., Mathivet, T., Siegfried, G., Kaminker, J. S., Larrivee, B., Breant, C., Duarte, A., Takakura, N., Fukamizu, A., et al. (2010) · Blood · doi:10.1182/blood-2010-02-270819 · Cited by 474
Genes that Distinguish Physiological and Pathological Angiogenesis
Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D., Graff-Cherry, C., & St. Croix, B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.017 · Cited by 419
The SCL gene specifies haemangioblast development from early mesoderm
Gering, M., Rodaway, A. R. F., Göttgens, B., Patient, R. K., & Green, A. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.4029 · Cited by 418
Self-citationEndothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis
Leslie, J. D., Ariza-McNaughton, L., Bermange, A. L., McAdow, R., Johnson, S. L., & Lewis, J. (2007) · Development · doi:10.1242/dev.003244 · Cited by 415
Liu, T., Qian, W.-J., Gritsenko, M. A., Camp, D. G., Monroe, M. E., Moore, R. J., & Smith, R. D. (2005) · Journal of Proteome Research · doi:10.1021/pr0502065 · Cited by 405
Regulation of Tumor Angiogenesis by EZH2
Lu, C., Han, H. D., Mangala, L. S., Ali-Fehmi, R., Newton, C. S., Ozbun, L., Armaiz-Pena, G. N., Hu, W., Stone, R. L., Munkarah, A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.016 · Cited by 399
Self-citationBubendorf, L., Nocito, A., Moch, H., & Sauter, G. (2001) · The Journal of Pathology · doi:10.1002/path.893 · Cited by 398
VHL and HIF signalling in renal cell carcinogenesis
Baldewijns, M. M., van Vlodrop, I. J., Vermeulen, P. B., Soetekouw, P. M., van Engeland, M., & de Bruïne, A. P. (2010) · The Journal of Pathology · doi:10.1002/path.2689 · Cited by 316
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D., Nam, E. J., Mora, E. M., Stone, R. L., Lu, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 282
Self-citationThe human and mouse repertoire of the adhesion family of G-protein-coupled receptors
Bjarnadóttir, T. K., Fredriksson, R., Höglund, P. J., Gloriam, D. E., Lagerström, M. C., & Schiöth, H. B. (2004) · Genomics · doi:10.1016/j.ygeno.2003.12.004 · Cited by 244
van Beijnum, J. R., Dings, R. P., van der Linden, E., Zwaans, B. M. M., Ramaekers, F. C. S., Mayo, K. H., & Griffioen, A. W. (2006) · Blood · doi:10.1182/blood-2006-02-004291 · Cited by 244
DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
Li, J.-L., Sainson, R. C. A., Oon, C. E., Turley, H., Leek, R., Sheldon, H., Bridges, E., Shi, W., Snell, C., Bowden, E. T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1704 · Cited by 224
Self-citationDieterich, L. C., Mellberg, S., Langenkamp, E., Zhang, L., Zieba, A., Salomäki, H., Teichert, M., Huang, H., Edqvist, P., Kraus, T., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4072 · Cited by 166
Sumanas, S., Jorniak, T., & Lin, S. (2005) · Blood · doi:10.1182/blood-2004-12-4653 · Cited by 159
Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications
Li, J., & Harris, A. L. (2009) · Frontiers in bioscience · doi:10.2741/3438 · Cited by 141
Self-citationThe EGF-TM7 family: a postgenomic view
Gordon, S., Lin, H., Hamann, J., Kwakkenbos, M. J., Kop, E. N., Stacey, M. A., & Matmati, M. (2004) · Immunogenetics · doi:10.1007/s00251-003-0625-2 · Cited by 131
Wallgard, E., Larsson, E., He, L., Hellström, M., Armulik, A., Nisancioglu, M. H., Genové, G., Lindahl, P., & Betsholtz, C. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165738 · Cited by 110
Sana, T. R., Janatpour, M. J., Sathe, M., McEvoy, L. M., & McClanahan, T. K. (2005) · Cytokine · doi:10.1016/j.cyto.2004.11.003 · Cited by 106
Yao, X., Qian, C.-N., Zhang, Z.-F., Tan, M.-H., Kort, E. J., Yang, X. J., Resau, J. H., & Teh, B. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0774 · Cited by 103
ETL, a Novel Seven-transmembrane Receptor That Is Developmentally Regulated in the Heart
Nechiporuk, T., Urness, L. D., & Keating, M. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004814200 · Cited by 102
Mutant-specific gene programs in the zebrafish
Weber, G. J., Choe, S. E., Dooley, K. A., Paffett-Lugassy, N., Zhou, Y., & Zon, L. I. (2005) · Blood · doi:10.1182/blood-2004-11-4541 · Cited by 94
GPCR homomers and heteromers: A better choice as targets for drug development than GPCR monomers?
Casadó, V., Cortés, A., Mallol, J., Pérez‐Capote, K., Ferré, S., Lluís, C., Franco, R., & Canela, E. I. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.07.005 · Cited by 93
ELTD1, a Potential New Biomarker for Gliomas
Towner, R. A., Jensen, R. L., Colman, H., Vaillant, B. D., Smith, N., Casteel, R., Saunders, D., Gillespie, D. L., Silasi‐Mansat, R., Lupu, F., et al. (2012) · Neurosurgery · doi:10.1227/neu.0b013e318276b29d · Cited by 83
Differential Endothelial Transcriptomics Identifies Semaphorin 3G as a Vascular Class 3 Semaphorin
Kutschera, S., Weber, H., Weick, A., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.215871 · Cited by 80
Ghilardi, C., Chiorino, G., Dossi, R., Nagy, Z., Giavazzi, R., & Bani, M. R. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-201 · Cited by 69
Herbert, J. M. J., Stekel, D. J., Sanderson, S., Heath, V. L., & Bicknell, R. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-153 · Cited by 63
An Acyltransferase Controls the Generation of Hematopoietic and Endothelial Lineages in Zebrafish
Xiong, J., Yu, Q., Zhang, J., & Mably, J. D. (2008) · Circulation Research · doi:10.1161/circresaha.107.163907 · Cited by 58
B, J. R. V. B., & Griffioen, A. W. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.06.001 · Cited by 42
Cited by
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Şenbabaoğlu, Y., Gejman, R. S., Winer, A. G., Liu, M., Van Allen, E. M., de Velasco, G., Miao, D., Ostrovnaya, I., Drill, E., Luna, A., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1092-z · Cited by 968
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Khan, K. A., & Kerbel, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.9 · Cited by 657
Consensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, P., Alitalo, K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., van Beijnum, J. R., Bender, R. H. F., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9613-x · Cited by 590
Self-citationMotzer, R. J., Robbins, P. B., Powles, T., Albiges, L., Haanen, J. B., Larkin, J., Mu, X. J., Ching, K. A., Uemura, M., Pal, S. K., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1044-8 · Cited by 518
Metadata
- Authors
- Masiero, M., Simões, F. C., Han, H. D., Snell, C., Peterkin, T., Bridges, E., Mangala, L. S., Wu, S. Y.-Y., Pradeep, S., Li, D., Han, C., Dalton, H., Lopez-Berestein, G., Tuynman, J. B., Mortensen, N., Li, J.-L., Patient, R., Sood, A. K., Banham, A. H., Harris, A. L., & Buffa, F. M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 24
- Issue
- 2
- Pages
- 229-241
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2097177355
- Cited by
- 313
- References
- 41
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.